Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-038888
Filing Date
2025-03-13
Accepted
2025-03-13 17:19:10
Documents
75
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K atyr-20241231.htm   iXBRL 10-K 2864030
2 EX-19.1 atyr-ex19_1.htm EX-19.1 63927
3 EX-19.2 atyr-ex19_2.htm EX-19.2 129248
4 EX-23.1 atyr-ex23_1.htm EX-23.1 12400
5 EX-31.1 atyr-ex31_1.htm EX-31.1 11969
6 EX-31.2 atyr-ex31_2.htm EX-31.2 12045
7 EX-32.1 atyr-ex32_1.htm EX-32.1 7906
8 EX-32.2 atyr-ex32_2.htm EX-32.2 7437
9 GRAPHIC img40158048_0.jpg GRAPHIC 1211132
  Complete submission text file 0000950170-25-038888.txt   14679831

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atyr-20241231.xsd EX-101.SCH 1523237
78 EXTRACTED XBRL INSTANCE DOCUMENT atyr-20241231_htm.xml XML 2175874
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37378 | Film No.: 25736891
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)